Bulk Resource
Order Form

Please fill out this form accurately to request bulk printed materials. All fields are required.

Bulk Resource
Order Form

Please fill out this form accurately to request bulk printed materials. All fields are required.

You Empower Our Work. Your gift will give more time to patients and caregivers.

You Empower Our Work. Your gift will give more time to patients and caregivers.

Ready to Fight with Us?

follow @FightCRC on social media

"Be your own advocate, and don't settle for less than you deserve." – Shannin Desroches 💙

Diagnosed with stage IV #coloncancer at 26, Shannin's symptoms started with abdominal pain and changes in bowel habits. By the time she got an MRI, she was rushed into emergency surgery.

Since then, she's faced surgery, egg retrieval, chemo, and now continues to fight for the chance to get surgery she doesn't yet qualify for.

Shannin is relentless. And we're proud to stand with her. Drop some love for her below. 👇
@shannindesroches
SAVE THE DATE!

Thursday, July 17 at 4pm ET 

GLP-1s are everywhere in the headlines, but what do they actually have to do with #colorectalcancer? 

Research is growing, the conversations are picking up, and CRC survivors have questions!

Join CEO Anjee Davis and VP of Disease Awareness Danielle Ripley Burgess LIVE on Instagram as they break it all down: what we know, what we're still learning, and what it could mean for those impacted by CRC.

💬 Got questions about GLP-1s and CRC? Drop them in the comments! We might answer them live!

@danielleisb
@anjeedavis
#ColorectalCancer survivors, we want to hear from YOU!

What's 1️⃣ thing that helped you through your diagnosis?
If you've finished chemotherapy and are still struggling with #neuropathy, you're not alone.

Around 58% of patients still experience chemotherapy-induced peripheral neuropathy (CIPN)—a.k.a. neuropathy—six months after treatment ends. It can affect your hands, feet, daily routines, and overall quality of life.

How has neuropathy impacted your life after treatment? Tell us below.